Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are pleased to announce that the University of Oxford MRC Brain Network Dynamics Unit joins the Nuffield Department of Clinical Neurosciences (NDCN) as a sixth division.

The MRC BNDU had its funding renewed earlier this year, and is developing its integrated approach to fundamental and translational neuroscience. NDCN as its new host department will be able to exploit existing collaborations with MRC BNDU researchers, as well as finding new ways to work together.

The MRC BNDU’s key strength is its focus on understanding and exploiting the moment-to-moment interactions between brain cells, particularly those involved in movement and memory. A deeper understanding of these circuits could help us develop interventions for when things go wrong in these brain mechanisms.

We in NDCN look forward to learning from the MRC BNDU’s exemplary approach to public engagement, staff development, data sharing and working with industry.

The Unit, led by Professor Peter Brown, will continue to have its main physical base next to the Department of Pharmacology on Mansfield Road. This will help to consolidate our foothold ‘down the hill’, first established by our Sleep and Circadian Neuroscience Institute, which is currently located in the Dunn School of Pathology.

Find out more at www.mrcbndu.ox.ac.uk/

Similar stories

New WA Handley Chair of Psychiatry Appointed

Strategic Developments

Professor John Geddes has been appointed to the WA Handley Professorship of Psychiatry and will take up this post in November 2021.

Investigating New Treatment for Schizophrenia

Research Highlights Strategic Developments

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim has been announced to investigate a new drug target for the treatment of schizophrenia.

Retirement of Professor Peter Brown

Strategic Developments

This month sees the retirement of Professor Peter Brown as Director of the Medical Research Council Brain Network Dynamics Unit at the University of Oxford.

The ALBA Declaration

Strategic Developments

Improving Equality, Diversity and Inclusiveness.

Recognition of Distinction Awards 2020

Awards and Honours Strategic Developments

It is a great pleasure to announce that a number of Neuroscience researchers have been successful in the recent assessment process for the conferment of the title of full Professor.

Ambitious Oxford initiative launched to address graduate under-representation

Strategic Developments

Oxford University and its colleges have announced a major new scholarship scheme for black graduate students as part of a programme to transform its graduate population by creating more funding opportunities for under-represented groups.